Citation Impact
Citing Papers
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
1997
Hedgehog signalling in cancer formation and maintenance
2003 Standout
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
The 2004 World Health Organization classification of lung tumors
2005 Standout
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
2003
Molecular pathogenesis of lung cancer
1999
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
2001
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
2002
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005 Standout
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers
1999
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Exosomal proteins as potential diagnostic markers in advanced non‐small cell lung carcinoma
2015
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
2001 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
1999
Molecular Pathogenesis of Lung Cancer
2002
Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non–Small-Cell Lung Cancer
2002
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States
2020
X-Tile
2004 Standout
Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer
2002
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
1997
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Ning Tu being referenced
Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
1995
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China
2020